SecBot SecBot
COURT-RULING ·Filed Nov 12, 2026

SYK

STRYKER CORP
NEUTRAL
Impact 3/10
Horizonmonths Processed4d 5h ago CourtCourt Ruling · govinfo.gov
Court ruling (district)
Actionable Insight • Neutral

Monitor the progression of this patent infringement case toward summary judgment or trial. The Markman ruling provides some clarity on claim scope but does not resolve infringement or validity. The deferred indefiniteness arguments could become material if they result in claim invalidation.

DirectionNeutral
Confidencehigh
Horizonmonths

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+1
Entry
$309.64
T+0 close · Nov 13, 2026 · via day close
Latest settled
+0.35%
T+1 · $310.72
Vs SPY
+2.26%
α at T+1
Next horizon
T+5
in 2d
  1. T+0 · Nov 13 $309.64entry
  2. T+1 · yesterday +0.35%α +2.26% · $310.72
  3. T+2 · todayOpen
  4. T+5 · in 2d Pending
  5. T+20 · in 26d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

The District of New Jersey issued a Markman claim construction opinion in Treace Medical Concepts v. Stryker Corp. The court adopted a mix of plaintiff and defendant constructions across 15 disputed terms in nine patents covering bunion correction systems. The ruling is an interlocutory step in the patent infringement case; no damages were awarded and no injunction was issued. For Stryker, the outcome is neutral, the case continues with some claim terms construed favorably to each side.

Court Ruling Details

Ruling Date
Nov 12, 2026
Court
United States District Court for the District of New Jersey
Court Level
District
Judge
Jamel K. Semper
Case Type
patent
Ruling Type
other
Outcome
PARTIAL: mixed ruling, some claims won/lost
Appeal Status
Interlocutory (case continues)

Key Facts

  • Court issued Markman claim construction opinion in Treace Medical Concepts v. Stryker Corp. et al.
  • Fifteen disputed terms across nine patents (US 9,622,805; 10,874,446; 11,039,873; 11,116,558; 11,602,386; 11,602,387; 11,911,085; 11,937,849; 11,950,819) were construed.
  • Court adopted plaintiff's construction for 'bone positioning guide', 'guide surface' and 'guiding surface' in the '849 Patent, and 'the bone positioning guide is fabricated from a radiolucent material'.
  • Court adopted defendants' construction for 'guide surface' in the '387 Patent, 'bone engagement member', 'tip', and 'system'.
  • Court adopted its own construction for 'main body member'.
  • Court deferred indefiniteness arguments on seven terms to summary judgment or trial.
  • No damages awarded, no injunction issued; the case remains pending.

Financial Impact

No financial impact stated in the ruling. The case is at an early claim construction stage with no damages or injunction.

Risk Factors

  • Adverse final judgment on patent infringement could result in damages or an injunction on Stryker's LapiFuse and PROstep bunion correction products.
  • Indefiniteness challenges to seven claim terms remain pending and could narrow or invalidate asserted claims at summary judgment or trial.

Market Snapshot

Exchange
NYSE
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
77% bullish (35 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 court opinion.

DocumentAccession Number
COURT-RULING Data (Synthetic)court-022d374c0d-SYK

Track record

29 reports on SYK

Performance horizon

5 of 9 bullish or bearish reports moved the stock their way by T+20. Best: +23.40% at T+20 after the Oct 7, 2026 report. 7 of 11 went positive at some point.

Filters
  1. Nov 12, 20266d ago Court Ruling Neutral 3/10 Viewing Entry $309.64 Now $310.72 +0.35% settles Dec 14
  2. Nov 9, 20268d ago 8-K Neutral 2/10 Entry $324.29 Now $310.72 −4.18% settles Dec 9
  3. Nov 5, 202612d ago 144 Neutral 3/10 Entry $325.87 Now $310.72 −4.65% settles Dec 7
  4. Nov 4, 202613d ago S-3ASR Neutral 3/10 Entry $335.08 Now $310.72 −7.27% settles Dec 4
  5. Nov 3, 202614d ago Institutional Cluster Mixed 3/10 Entry $310.55 Now $310.72 +0.05% settles Dec 2
  6. Oct 29, 202619d ago 8-K Bearish 6/10 No price data
  7. Oct 29, 202619d ago Press Release Bearish 6/10 Entry $291.86 Now $310.72 −6.46% settles Nov 30
  8. Oct 26, 202622d ago Press Release Neutral 4/10 Entry $306.13 Now $310.72 +1.50% settles Nov 23
  9. Oct 20, 202629d ago PTAB Trial Bearish 5/10 Entry $297.60 Now $310.72 −4.41% settles Nov 18
  10. Oct 7, 20265w ago ANALYST-UPGRADE Bullish 4/10 Entry $275.25 to $339.65 Now $310.72 +12.89% ▲ +23.40% +24.74% vs SPY
Showing 10 of 29

US Market Status

Market Closed · Opens Thu (12h 1m)

Subscribe to SecBot

Get Real-Time Court Ruling Intelligence

Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more, parsed and scored by AI.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
⚖ Court Ruling · govinfo.gov Report published Nov 13, 2026